Related Experiment Video
Updated: May 1, 2026

Measuring Carbon Content in Airway Macrophages Exposed to Carbon-Containing Particulate Matters
Published on: July 12, 2024
The role of microparticles in chronic obstructive pulmonary disease
Toru Takahashi1, Hiroshi Kubo2
1Department of Advanced Preventive Medicine for Infectious Disease, Tohoku University Graduate School of Medicine, Sendai, Japan ; Cellular and molecular lung biology research units, Institut de Recherches Cliniques de Montréal (IRCM), Montreal, Quebec, Canada ; Department of Anesthesiology, Tohoku University Hospital, Sendai, Japan.
Abstract:
Accumulating evidence suggests that cell injury in lung tissues is closely connected to disease progression in chronic obstructive pulmonary disease (COPD). Microparticles (MPs) are shed membrane vesicles that are released from platelets, leukocytes, red blood cells, and endothelial cells when these cells are activated or undergo apoptosis under inflammatory conditions. Based on increasing evidence that endothelial injury in the pulmonary capillary vasculature leads to lung destruction, and because cardiovascular diseases are the main cause of death among individuals with COPD, endothelial MPs (EMPs) are now receiving attention as potential biomarkers for COPD. There are eight types of EMPs which are defined by the presence of different endothelial markers on the cell membrane: vascular endothelial-cadherin; platelet endothelial cell adhesion molecule; melanoma cell adhesion molecule; E-selectin; CD51; CD105; von Willebrand factor; and CD143 EMPs. Vascular endothelial-cadherin, platelet endothelial cell adhesion molecule, and E-selectin EMPs are increased in patients with stable COPD and are further increased in patients with exacerbated COPD compared to non-COPD patients. In addition, the levels of these three EMPs in patients with stable COPD are significantly correlated with lung destruction and airflow limitation. These results indicate that endothelial injury is closely connected to the pathophysiology of COPD. Interestingly, the variations in the levels of the eight EMP subtypes were not identical with changes in patient condition. Although the clinical significance of the differences in these eight EMP subtypes remains unclear, evaluating the expression pattern of endothelial antigens on circulating MPs might predict the presence and degree of endothelial injury in COPD patients. In addition, circulating MPs are proposed to have several physiological functions in vivo, such as intercellular crosstalk; the increase in EMPs in COPD seems to play a role in the pathophysiology of this disease.
Insights
Endothelial microparticles (EMPs) indicate cell injury in chronic obstructive pulmonary disease (COPD). Elevated EMPs correlate with lung destruction and airflow limitation, suggesting their role as biomarkers for COPD progression.
Area of Science:
- Pulmonary Medicine
- Cardiovascular Research
- Cell Biology
Background:
- Cell injury in lung tissue is linked to chronic obstructive pulmonary disease (COPD) progression.
- Endothelial injury in pulmonary capillaries contributes to lung destruction and cardiovascular disease, a leading cause of death in COPD patients.
- Endothelial microparticles (EMPs) are emerging as potential biomarkers for COPD due to their association with endothelial injury.
Purpose of the Study:
- To investigate the role of endothelial microparticles (EMPs) as potential biomarkers for chronic obstructive pulmonary disease (COPD).
- To assess the correlation between specific EMP subtypes and the severity of lung destruction and airflow limitation in COPD patients.
Main Methods:
- Analysis of eight distinct EMP subtypes defined by specific endothelial markers.
- Comparison of EMP levels in stable COPD, exacerbated COPD, and non-COPD individuals.
- Correlation analysis between EMP levels and clinical parameters such as lung destruction and airflow limitation.
Main Results:
- Levels of vascular endothelial-cadherin, platelet endothelial cell adhesion molecule, and E-selectin EMPs are elevated in stable and exacerbated COPD patients compared to controls.
- These specific EMP levels significantly correlate with lung destruction and airflow limitation in COPD patients.
- Variations in the levels of different EMP subtypes were observed, suggesting complex pathophysiological roles.
Conclusions:
- Endothelial injury is closely associated with the pathophysiology of COPD.
- Specific EMP subtypes show promise as predictive biomarkers for COPD severity and progression.
- Further research into the differential expression patterns of EMP subtypes may elucidate their clinical significance in COPD.
More Related Videos
08:17Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
10:26P. aeruginosa Infected 3D Co-Culture of Bronchial Epithelial Cells and Macrophages at Air-Liquid Interface for Preclinical Evaluation of Anti-Infectives
Published on: June 15, 2020
Related Concept Videos
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations
Chronic Obstructive Pulmonary Disease-I: Introduction